PD-1<sup>+</sup> Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Marco,Donia

第一单位： Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. marco.donia@regionh.dk inge.marie.svane@regionh.dk.;Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.

作者： Marco,Donia ^[1] ; Julie Westerlin,Kjeldsen ^[2] ; Rikke,Andersen ^[3] ; Marie Christine Wulff,Westergaard ^[2] ; Valentina,Bianchi ^[4] ; Mateusz,Legut ^[4] ; Meriem,Attaf ^[4] ; Barbara,Szomolay ^[5] ; Sascha,Ott ^[6] ; Garry,Dolton ^[4] ; Rikke,Lyngaa ^[7] ; Sine Reker,Hadrup ^[7] ; Andrew K,Sewell ^[5] ; Inge Marie,Svane ^[1]

作者单位： Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. marco.donia@regionh.dk inge.marie.svane@regionh.dk.;Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. ^[1] Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. ^[2] Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.;Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. ^[3] Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom. ^[4] Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.;Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom. ^[5] Department of Computer Science, University of Warwick, Coventry, United Kingdom. ^[6] Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Copenhagen, Denmark. ^[7]